Related Experiment Videos
Isradipine and the coronary circulation
R O Feneck1, S M Underwood, R K Walesby
1Department of Cardiothoracic Anaesthesia, London Chest Hospital, UK.
Insights
Isradipine effectively dilates coronary arteries without negatively impacting heart function. This makes it a potentially beneficial vasodilator for patients undergoing myocardial revascularization procedures.
Area of Science:
- Cardiovascular Pharmacology
- Cardiac Surgery
Background:
- Isradipine is recognized as an effective vasodilator across various vascular beds.
- Previous research indicates isradipine's potent vasodilatory effects, particularly in the coronary arteries.
Purpose of the Study:
- To evaluate the efficacy of isradipine as a coronary vasodilator.
- To assess the impact of isradipine on cardiac contractility and conduction in clinical settings.
Main Methods:
- Review of experimental evidence on isradipine's vasodilatory properties.
- Analysis of clinical studies in cardiology and cardiac surgery involving isradipine.
Main Results:
- Isradipine demonstrates potent coronary vasodilation.
- Clinical studies showed no significant adverse effects on cardiac contractility or conduction.
Conclusions:
- Isradipine's vasodilatory action is effective in the coronary vasculature.
- The absence of negative cardiac effects suggests potential benefits for patients undergoing myocardial revascularization.
Abstract:
Isradipine has been shown to be an effective vasodilator in different vascular beds. Experimental evidence suggests that isradipine is a potent coronary vasodilator, and this is supported by clinical studies in both cardiology and cardiac surgery. Furthermore, in these studies, coronary vasodilation was not accompanied by evidence of any significant effect on cardiac contractility or conduction. It can be concluded that the cardiac effects of isradipine will ultimately prove to be beneficial in patients undergoing myocardial revascularization.